• EE346 The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter

    Jul 1, 2025, 00:00

  • PCR216 Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach

    Jul 1, 2025, 00:00

  • PCR92 Renal Cell Carcinoma and Muscle Invasive Bladder Cancer Patients' Perception of Risk and Fear of Recurrence

    Jul 1, 2025, 00:00

  • Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States

    Jul 1, 2025, 00:00

  • PCR237 Evaluating Thresholds for Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures (PROMs) in Locally Advanced or Metastatic Urothelial Cancer (la/mUC): a Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • HPR82 Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals

    Jul 1, 2025, 00:00

  • EPH162 Real-World Demographic and Clinical Characteristics of Patients With Atherosclerotic Cardiovascular Disease With or Without Chronic Kidney Disease or Systemic Inflammation in the United States

    Jul 1, 2025, 00:00

  • RWD150 The HER2-TRENDS StudyHR Positive - HER2 Negative Metastatic Breast Cancer (mBC) Treatment Patterns and Clinical Outcomes in Canada

    Jul 1, 2025, 00:00

  • Reviewer Acknowledgment

    Jul 1, 2025, 00:00

  • RWD7 Youth Mental Health Crisis: Economic Impacts and HEOR Opportunities

    Jul 1, 2025, 00:00

  • OP8 Framework for Real-World Data Used in Regulatory Submissions

    Jul 1, 2025, 00:00

  • PCR147 Comparison of Rare Disease Patient and Caregiver Perceptions Regarding Access to Disease Information and Interactions with their Healthcare Providers: Results from an International Survey

    Jul 1, 2025, 00:00

  • P32 Oncology Trial Emulation Using Real-World Electronic Health Record Data: Results of the Coalition to Advance Real-World Evidence Through Randomized Controlled Trial Emulation (CARE) Initiative

    Jul 1, 2025, 00:00

  • HSD25 Efficacy of Improvisational Communication Training for Health Workers in Emergency Care Unit in Hungary: Quazy Experimental Study

    Jul 1, 2025, 00:00

  • MSR146 Identifying Redundant or Misfitting Items Using Item Response Theory: Type I and II Error Rates for Item Local Dependence and Misfit Detection in Clinical Outcome Assessments

    Jul 1, 2025, 00:00

  • HSD54 Receipt of Guideline Concordant Treatment Among Older Adults Newly Diagnosed With Stage III - IV Melanoma Using SEER-Medicare Linked Data

    Jul 1, 2025, 00:00

  • RWD151 Real-World Evidence on the Use of Secondary Prevention for People With ASCVD or CKD: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report

    Jul 1, 2025, 00:00

  • EE477 Healthcare Costs and Resource Utilization Associated With Knee Osteoarthritis and Obesity in the United States: A Retrospective Database Study

    Jul 1, 2025, 00:00

  • EE341 Economic Burden of Prader-Willi Syndrome Among Pediatric Patients in the United States

    Jul 1, 2025, 00:00

  • PCR93 Beyond Clinical Data: Assessing Usage Patterns of Real-World Home-Reported Outcomes To Capture the Full Burden of Atopic Dermatitis Symptoms and Flares

    Jul 1, 2025, 00:00

  • EPH139 How is Patient Safety Addressed in Pharmacy Degree Programs in Brazil?

    Jul 1, 2025, 00:00

  • HPR73 Analysis of Out-of-Pocket Payments Associated with Female Infertility in Hungary Between 2015-2023

    Jul 1, 2025, 00:00

  • EE463 A Longitudinal Year-by-Year Cost Analysis for Patients Diagnosed with Polycythemia Vera

    Jul 1, 2025, 00:00

  • P27 Use of Metamodels in Health Economics to Bypass Complexity and Democratize Modeling

    Jul 1, 2025, 00:00

  • HTA64 Validation of Artificial Intelligence (AI) Tool to Identify PICO Questions for EU Joint Clinical Assessment (JCA)

    Jul 1, 2025, 00:00

  • P50 Quantifying Treatment Value Using Alternative Health Benefit Metrics: A Case Study of Adjuvant Osimertinib for Elderly Patients with EGFR mutated NSCLC Following Resection

    Jul 1, 2025, 00:00

  • MSR17 A Comparative Assessment of LLM Agreement for Clinical Data Extraction Tasks

    Jul 1, 2025, 00:00

  • EE324 Cost Analysis of Surgical Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Refractory to Clinical Therapy in Brazil

    Jul 1, 2025, 00:00

  • EE231 The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in the UK

    Jul 1, 2025, 00:00

  • RWD34 Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities

    Jul 1, 2025, 00:00

  • CO5 Patient Journey Prior to the Diagnosis of Niemann-Pick Disease Type C

    Jul 1, 2025, 00:00

  • EE443 Costs Avoided by the Inclusion of Finerenone Based on Hospitalization and Death Due to Cardiovascular Events and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jul 1, 2025, 00:00

  • PCR149 Patient Optimism and the Trade-Off Between Kidney Quality and Waiting Time

    Jul 1, 2025, 00:00

  • CO55 A Retrospective Real-World Data Analysis of Pregnancy Outcomes Among Women with a History of Hysteroscopic Intrauterine Adhesiolysis (HA), Other Intrauterine Surgery (IUs), or no Prior IUs

    Jul 1, 2025, 00:00

  • MT27 Impact of Single-Patient use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in the USA

    Jul 1, 2025, 00:00

  • EE337 Economic Burden of Rheumatoid Arthritis in Low- and Middle-Income Countries: Systematic Review

    Jul 1, 2025, 00:00

  • EPH31 Prevalence of Hypertension Over (Calendar) Time Among People With Narcolepsy Treated With Oxybate

    Jul 1, 2025, 00:00

  • HSD2 Cognitive Impairment at Initial Diagnosis of Alzheimer’s Disease: Patient Characteristics and Treatments in the Real-World Setting

    Jul 1, 2025, 00:00

  • EE309 Examination of the Two-Year US Commercial Payer Budget Impact (BI) of the Leva Pelvic Health System, a Prescription Medical Device That Provides Supervised Pelvic Floor Muscle Training (PFMT) As First-Line Treatment for Female Urinary ...

    Jul 1, 2025, 00:00

  • EPH111 Epidemiology of Polymyalgia Rheumatica: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HPR154 The Impact of the Inflation Reduction Act on Rare Diseases and Orphan Drugs

    Jul 1, 2025, 00:00

  • RWD24 Optimizing EHR Data Completeness: A Conceptual Framework for Bringing Real-World Data into Clinical Research through Relevant Completeness

    Jul 1, 2025, 00:00

  • RWD44 Clinical Validation of Large Language Model for Automated Extraction of Genetic Testing Data

    Jul 1, 2025, 00:00

  • EPH101 National Respiratory Surge Forecasting With Combined Pharmacy and Public Health Data

    Jul 1, 2025, 00:00

  • RWD18 Treatment Patterns and Healthcare Resource Utilization in Patients Diagnosed With CRSwNP in HMO From Colombia: A Real Word Evidence Study

    Jul 1, 2025, 00:00

  • MSR51 Maximizing the Impact of In-Trial Interviews Through AI Assisted Analysis

    Jul 1, 2025, 00:00

  • MT39 Real-World Clinical Outcomes, Healthcare Resource Utilization, and Direct Medical Costs in Atrial Fibrillation Patients Receiving Catheter Ablation in Japan

    Jul 1, 2025, 00:00

  • EE376 Treatment Patterns and Healthcare Resource Utilization of Patients Early in Schizophrenia Illness Initiating Aripiprazole Lauroxil Versus Oral Aripiprazole: A Retrospective Claims-Based Study

    Jul 1, 2025, 00:00

  • EE322 Cost and Clinical Characteristics of Acute Pancreatitis Hospitalizations Related and Unrelated to Hypertriglyceridemia

    Jul 1, 2025, 00:00

  • EE408 Healthcare Resource Utilization And Costs Following Disease Progression With First-Line Systemic Therapy In Patients With Advanced Endometrial Cancer in the US

    Jul 1, 2025, 00:00

  • EE351 Cost-Utility Analysis of Sequential Therapy of iCT IRd and DRd strategy for Newly Diagnosed Multiple Myeloma Patients Who are Transplant-Ineligible in China

    Jul 1, 2025, 00:00

  • MSR97 An “R-Shiny” Interface Designed As a One-Stop Solution for All Kinds of Indirect Treatment Comparisons According to NICE Technical Support Documents 2, 3, and 18

    Jul 1, 2025, 00:00

  • MT17 Digital Health Interventions and Environmental Sustainability: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • RWD171 Baseline BMI and HbA1c Trends in US Diabetic Patients Initiating GLP-1 Therapy: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • MSR136 Augmenting Race and Ethnicity in a Real-World Oncology Cohort Using the Bayesian Improved Surname Geocoding Methodology

    Jul 1, 2025, 00:00

  • HPR83 China's National Reimbursement Drug List (NRDL) Negotiation: Value Considerations and Key Factors Influencing Payment Standards

    Jul 1, 2025, 00:00

  • HSD104 Colorectal Cancer Screening Initiation Among Newly Age-Eligible Medicaid-Insured Individuals in Texas

    Jul 1, 2025, 00:00

  • PCR177 Patient-Reported Outcomes in Indirect Treatment Comparisons: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE524 Millions in Annual National Savings Could Be Realized From Improving the Quality of Uterotonic Medications in Sub-Saharan Africa

    Jul 1, 2025, 00:00

  • CO77 External Control Arm With Real World Data to Assess the Effect of Semaglutide on Chronic Kidney Disease Risk Among Patients With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • MSR74 Data Extraction from Full-Text PDFs Using Large Language Models for Systematic Reviews

    Jul 1, 2025, 00:00

  • EPH12 Estimating Epidemiological Estimates of Rare Diseases in Reimbursement Submissions to Canada's Drug Agency: A Comparison of Approaches in the Absence of Local Real-World Data

    Jul 1, 2025, 00:00

  • PCR57 Investigating the Potential of Extracting Answers to Health-Related Quality of Life Questionnaires From Patient Community Data

    Jul 1, 2025, 00:00

  • HPR112 Impact of New Cervical Cancer Screening Program Using Human Papillomavirus (HPV) Deoxyribonucleic Acid (DNA) Testing on Urban-Rural Disparities in Thailand: A Post-Hoc Distributional Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • HSD65 Telehealth Use Among Adultswith Sickle Cell Disease in Texas Medicaid Before and During the Covid-19 Pandemic

    Jul 1, 2025, 00:00

  • HSD106 Assessing Infection Prevention Staffing and Resource Allocation Across Single and Multi-Facility Hospitals: A Comparative Analysis

    Jul 1, 2025, 00:00

  • HPR8 Healthcare Across Borders: Changes in Physician Numbers and Spatial Inequalities in Hungary and the DACH Countries (Austria, Germany, Switzerland)

    Jul 1, 2025, 00:00

  • EE344 Evaluating the Budget Impact of an Intrauterine Device for Postpartum Hemorrhage Management: A Hospital Perspective

    Jul 1, 2025, 00:00

  • PT24 A Quantitative Exploration of Challenges to the Sustainability of the United States Biosimilar Market

    Jul 1, 2025, 00:00

  • PCR30 Perfect Health Reporting on EQ-5D-5L: The Role of Personal, Family and Social Network Illness Experiences

    Jul 1, 2025, 00:00

  • MT22 Hope as a Catalyst: AI-Based Conversational Agents in Mental Health Support

    Jul 1, 2025, 00:00

  • HPR92 Evolution of Technology Diffusion within Brazilian Universal Healthcare System (Sistema Único de Saúde - SUS) 2+ Years After Listing of Antiangiogenics Treatment for Age-Related Macular Edema (AMD)

    Jul 1, 2025, 00:00

  • PCR44 Characterizing the Experience of Excessive Daytime Sleepiness in Patients with Idiopathic Hypersomnia: Implications for Measuring Daytime Sleepiness with the Epworth Sleepiness Scale in a Clinical Trial (NCT05156047)

    Jul 1, 2025, 00:00

  • EPH47 Characteristics Correlated with Limited Physical Functioning in US Adults with Arthritis: A Cross-Sectional Database Analysis of the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE522 Long-Term Cost-Effectiveness Analysis of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogues in Patients With Type 2 Diabetes in China

    Jul 1, 2025, 00:00

  • MSR42 Three Different Methods to Estimate a Rare Disease (RD) Prevalence in a Country with a Limited Dataset: Which One Fits?

    Jul 1, 2025, 00:00

  • EE414 Impact Analysis of Statin Discontinuation on Healthcare Resource Utilization (HCRU) and Cost of Care in Patients With Atherosclerotic Cardiovascular Disease (ASCVD) in the US

    Jul 1, 2025, 00:00

  • PCR136 Consumer and Healthcare Provided Preferences for Adult Combination COVID-19 and Influenza Vaccines: Results from a Discrete Choice Study in France, Italy and Germany

    Jul 1, 2025, 00:00

  • RWD55 A Large Language Model Approach for Evaluating Real-World Evidence in FDA Approvals

    Jul 1, 2025, 00:00

  • HSD26 Cancer Survivors and Opioid Use During Survivorship - A Scoping Review

    Jul 1, 2025, 00:00

  • HSD70 Importance of Virtual Access for Mental Health Services: Evidence from ESI Population

    Jul 1, 2025, 00:00

  • HTA88 What's Cost Got To Do With It? A Review of Key Issues Related to Costs in Health Technology Assessments in Non-Small-Cell Lung Cancer

    Jul 1, 2025, 00:00

  • CO49 Prognostic or Predictive Factors in Biliary Tract Cancer: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HSD99 Geographic Inequities in Bariatric Surgery Access in Southern Chile: The Case of the Chilean Bundled Payment PAD

    Jul 1, 2025, 00:00

  • P55 Access to Care and Ability to Afford Prescription and Medical Treatment Among Adults With Obesity in the United States

    Jul 1, 2025, 00:00

  • PCR163 Effectiveness of Co-Creation Physical Literacy Intervention on Weight Control and Physical Fitness Among Obese Children: A PreliminaryInvestigation

    Jul 1, 2025, 00:00

  • PT3 An Artificial Intelligence (AI)-Assisted Systematic Literature Review (SLR) of the Economic Burden in Metastatic Pancreatic Adenocarcinoma: A Proof-of-Concept Study

    Jul 1, 2025, 00:00

  • EPH74 Characteristics of Patients Initiating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (RAs) for Cardiometabolic Risk Reduction in a Medicare Population

    Jul 1, 2025, 00:00

  • MSR104 Revolutionizing Multi-Level Network Meta-Regression: Advancing Analysis With the Package

    Jul 1, 2025, 00:00

  • CO95 Comparative Efficacy, Safety, and Tolerability of Xanomeline and Trospium Chloride versus Eight Atypical Antipsychotics for the Acute Treatment of Adults with Schizophrenia - A Network Meta-Analysis

    Jul 1, 2025, 00:00

  • HTA35 Economic Analysis of an Optical Neonatal Skin Maturity Meter (MOMPN) in Brazilian Newborns

    Jul 1, 2025, 00:00

  • HPR96 The Changing Impact of the Inflation Reduction Act on Payer Utilization Management- Insights from an Ongoing Quantitative Survey

    Jul 1, 2025, 00:00

  • PCR45 Rethinking Women's Health: Unpacking the 2024 Women's Health Research Roadmap With a Landscape Review of Clinical Outcome Assessments (COA), Health Agency Recommendations and Drug Label Claims With COA Related to Women's Health

    Jul 1, 2025, 00:00

  • CO62 Comparison of Central Venous Access Device Insertion Proportions, Costs and Removal Time Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Early Breast Cancer Patients

    Jul 1, 2025, 00:00

  • PCR101 Association of Chronic Conditions and Medication Burden with Patient Preferences for Long-Acting Antiretroviral Therapy in HIV Treatment

    Jul 1, 2025, 00:00

  • The Argument-Based Approach to Validity Applied to Clinical Outcome Assessments: Some History and Notable Features

    Jul 1, 2025, 00:00

  • MSR126 Data-Based Lumping and Splitting of Treatments in Network Meta-Analysis in the Presence of Heterogeneity: A Flexible Non-Parametric Bayesian Approach

    Jul 1, 2025, 00:00

  • PT27 Cost-Effectiveness of Delaying Progression of Alzheimer's Disease with Novel Monoclonal Antibodies: A Societal Perspective

    Jul 1, 2025, 00:00

  • HTA78 Assessing the Acceptance of Single-Arm Trials in Health Technology Appraisals: A Review of NICE, CADTH, HAS, and NCPE Appraisals in 2024

    Jul 1, 2025, 00:00

  • EPH59 Application of Prevalent New-User Cohort Designs to a Claims Data Study of Incidence of Nutritional Deficiency in People With Diabetes Using GLP-1 Receptor Agonists

    Jul 1, 2025, 00:00

  • EE398 Cost Comparison of Osimertinib Plus Chemotherapy Versus Amivantamab Plus Lazertinib for the First-Line Treatment of Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC

    Jul 1, 2025, 00:00

  • EE437 Out-of-Pocket Health Care Spending Among Medicare Beneficiaries Before and During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • EPH43 The Association Between COVID-19 Vaccination History and the Incidence of COVID-19 and Healthcare Resource Use in Rural Residents in Japan

    Jul 1, 2025, 00:00

  • PT14 Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies

    Jul 1, 2025, 00:00

  • RWD144 Travel Burden of Beta-Thalassemia Patients Receiving Red Blood Cell Transfusions in the Brazilian Public Healthcare System: A Real-World Study

    Jul 1, 2025, 00:00

  • EPH19 Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic

    Jul 1, 2025, 00:00

  • P18 Disparities in Antipsychotic Prescribing Among the US Medicare Population

    Jul 1, 2025, 00:00

  • EPH116 Informing Blood Donor Safety and Blood Supply Management in the United States: Factors Affecting Donor Time-To Return After Low Hemoglobin Deferral

    Jul 1, 2025, 00:00

  • MSR21 Do Lifetables Overestimate Non-Cancer-Specific Survival (NCSS) in Oncology? A Case Study From Treatment-Naïve Advanced Melanoma

    Jul 1, 2025, 00:00

  • HPR139 Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases

    Jul 1, 2025, 00:00

  • EE348 A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities

    Jul 1, 2025, 00:00

  • EE389 Cost-Effectiveness of Pembrolizumab as First-Line Treatment for Patients with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Unresectable or Metastatic Colorectal Cancer (CRC) from Public Payer Perspective ...

    Jul 1, 2025, 00:00

  • EE270 Cost-Effectiveness Analysis of Tisagenlecleucel for Third-Line Treatment With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

    Jul 1, 2025, 00:00

  • Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions

    Jul 1, 2025, 00:00

  • HTA46 Fostering the Identification and Dissemination ofHealth Technology Assessment Studies: The Brazilian HTA Database Case Study

    Jul 1, 2025, 00:00

  • EPH24 Sodium Glucose Co-Transporter 2 Inhibitor Exposure and the Risk of Congenital Malformations: Nationwide Birth Cohort Study

    Jul 1, 2025, 00:00

  • EE280 Clinical and Economic Analysis in Rheumatoid Arthritis Treatment: A Managed Care Experience

    Jul 1, 2025, 00:00

  • PCR53 Redesigning the Care Process to Improve the Experience of Patients with Multiple Sclerosis Throughout the Patient Journey. EMpodera

    Jul 1, 2025, 00:00

  • HTA89 Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA

    Jul 1, 2025, 00:00

  • HSD62 Ten-Year Trends in Potentially Inappropriate Sedative-Hypnotics and Pain Medication Use among Medicare Part D Beneficiaries

    Jul 1, 2025, 00:00

  • CO40 Real-World Patient Characteristics and Treatment Patterns in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Long-Term Survivorship

    Jul 1, 2025, 00:00

  • MSR3 Parametric Model Selection: Beyond AIC/BIC in Health Economic Context

    Jul 1, 2025, 00:00

  • PCR205 What Is the Level of Agreement between Family Caregivers and Their Children Living with Rheumatic Disease in Reporting Health-Related Quality of Life?

    Jul 1, 2025, 00:00

  • MSR144 Physician-Augmented AI: Improving Machine Learning-Based Detection of NSCLC and Associated Clinical Indicators

    Jul 1, 2025, 00:00

  • PCR56 Translation and Cultural Adaptation of the Pain Impact Questionnaire (PIQ-6) Among Chronic Pain Patients in Japan

    Jul 1, 2025, 00:00

  • Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making

    Jul 1, 2025, 00:00

  • MSR143 Developing a Large Language Model-Based Simulation for PT Committees: Methodology and Inputs for Realistic Dynamics

    Jul 1, 2025, 00:00

  • EE435 Integration of Environmental Considerations in Economic Evaluations: Significant Shift or Token Gesture? Insights From Severe Asthma Treatments

    Jul 1, 2025, 00:00

  • OP9 Budget Impact Model of Enhanced Lung Cancer Screening With AI/ML Tech-Based Software as a Medical Device (SaMD) on a US Cohort and Private Payer Perspective

    Jul 1, 2025, 00:00

  • HPR117 Racial Disparities in Biomarker Testing Rate, First-Line (1L) Treatment Patterns and Clinical Outcomes Among Real-World Patients in the United States (US) with Advanced or Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jul 1, 2025, 00:00

  • A Scoping Review of Interventions to Reduce the Environmental Footprint of Healthcare

    Jul 1, 2025, 00:00

  • HSD16 Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey

    Jul 1, 2025, 00:00

  • PCR130 Health-Related Quality of Life (HRQoL) of Large B-cell Lymphoma (LBCL) and Follicular Lymphoma (FL) Patients Treated with Axicabtagene Ciloleucel (Axi-cel) in Clinical Trials and the Real-World: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HPR20 Collaborations Between Pharma and Digital Health Startups: Advancing Innovation and Reimbursement in Digital Health Technologies

    Jul 1, 2025, 00:00

  • EPH85 Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA Discontinuation

    Jul 1, 2025, 00:00

  • HPR39 Health Insurance Use Among Young Pharmacists in Nigeria

    Jul 1, 2025, 00:00

  • CO16 The Impact of Glucocorticoid (GC) Dose on Clinical Outcomes in Congenital Adrenal Hyperplasia (CAH): A Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • EE286 Cost-Effectiveness of NALIRIFOX As a First-Line Treatment for Metastatic Pancreatic Cancer in Taiwan

    Jul 1, 2025, 00:00

  • MSR33 Automated Extraction of Kaplan-Meier Survival Curves Using Generative Artificial Intelligence and Computer Vision

    Jul 1, 2025, 00:00

  • SA6 Changes in HbA1c and Body Weight in US Adults With Type 2 Diabetes and Chronic Kidney Disease Who Received Oral Semaglutide

    Jul 1, 2025, 00:00

  • RWD53 Burden of Illness and Healthcare Resource Utilization (HCRU) for Chronic Obstructive Pulmonary Disease (COPD) in Ontario, Canada

    Jul 1, 2025, 00:00

  • EE258 Burden of Systemic Light-Chain (AL) Amyloidosis by Mayo Stage: Results From an Electronic Health Record (EHR) Linked To Claims Analysis

    Jul 1, 2025, 00:00

  • CO70 Cannabinoids for Symptom Management in Children and Adolescents with Autism Spectrum Disorder: A systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • EPH107 Patient-Provider Herpes Zoster Vaccination Discussion: Insights From Observed Primary Care Visits in the United States

    Jul 1, 2025, 00:00

  • PCR71 Insights from a Shared-Decision Making Appointment Preparation Process in an Eczema Self-Monitoring Mobile Health App

    Jul 1, 2025, 00:00

  • EE485 Economic Evaluations of Preventive Interventions for Self-Harm and Suicide: A Systematic Review

    Jul 1, 2025, 00:00

  • PCR230 Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy

    Jul 1, 2025, 00:00

  • HTA59 Revisiting Archetypes: New Archetypes for Strategic Global Value Evidence Planning

    Jul 1, 2025, 00:00

  • MSR153 Frequently Asked Questions (FAQs): What Are the Risks and Mitigation Strategies in Using Gen-AI in HEOR?

    Jul 1, 2025, 00:00

  • HPR65 Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment and Prioritization Decisions

    Jul 1, 2025, 00:00

  • MSR94 To Bootstrap, or Not to Bootstrap Before Multiple Imputation: That Is the Question

    Jul 1, 2025, 00:00

  • HTA28 Health Equity and HTA: Is Equity Data Shaping Recommendations

    Jul 1, 2025, 00:00

  • HSD87 Chimeric Antigen Receptor T Cell (CAR T) Therapy As Second-Line (2L) Treatment for Patients With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Therapy Choice and Treatment Barriers Among US Oncologists

    Jul 1, 2025, 00:00

  • Use of Real-World Data to Support Economic Evaluations of Tumor-Agnostic Therapies: Challenges Remain

    Jul 1, 2025, 00:00

  • PCR198 Evaluating the Influence of User-Complexity on Individual Preferences for Upper Limb Prosthetic Selection: Measurement Tool Development for a Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • MT21 A New-to-Market Single-Use Ureteroscope: Urologist Performance Rating and Capability Assessment

    Jul 1, 2025, 00:00

  • EPH154 Racial Differences in Health Status Among Newly Diagnosed Type 2 Diabetes

    Jul 1, 2025, 00:00

  • RWD80 Presenteeism in Employees with Chronic Conditions: An Analysis Using Linked Claims and Self-Reported Employee Health Risk Assessment Data

    Jul 1, 2025, 00:00

  • EE241 Cost-Savings of Primary Healthcare Nurse Practitioners' Planned Interventions for Reducing Transfers of Patients from Home Care to Emergency Departments in Quebec, Canada

    Jul 1, 2025, 00:00

  • MT38 Does a Digital Health Program Influence One’s Choice of Traditional Health Care? Changes in Health Care Use and Episodic Cost Among a Group of Chronic MSK Patients in a Digital Conservative Musculoskeletal Care Program

    Jul 1, 2025, 00:00

  • PCR24 Impact of Herpes Zoster Ophthalmicus on Healthcare Utilization and Patient Reported Outcomes: Results from a Multicenter Cohort Study

    Jul 1, 2025, 00:00

  • HTA25 Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making

    Jul 1, 2025, 00:00

  • RWD148 Epidemiological Estimates of Interstitial Lung Diseases in Mexico: A Real-World Data Analysis of 2,591,278 Hospital Discharges From the Ministry of Health

    Jul 1, 2025, 00:00

  • HTA2 Role of Relative Dose Intensity in Health Economic Evaluations: A Review of National Institute for Health and Care Excellence Technology Appraisals of Treatments in Solid Tumors

    Jul 1, 2025, 00:00

  • EPH8 Natural History and Burden of Disease Among Patients With Juvenile GM2 Gangliosidoses in France

    Jul 1, 2025, 00:00

  • MSR141 Reconciling Discrepancies in Results with Different Population-adjusted Indirect Comparison (PAIC) Methods

    Jul 1, 2025, 00:00

  • RWD10 Characterizing Cardiovascular Disease Patients in US Community Hospitals Using InsightsDB

    Jul 1, 2025, 00:00

  • EE333 A Budget Impact Analysis of Introducing OPSYNVI for the Treatment of Adult Patients Diagnosed With Pulmonary Arterial Hypertension

    Jul 1, 2025, 00:00

  • P26 VBA and R to Automate Health Economic Model Programming

    Jul 1, 2025, 00:00

  • EE372 Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada

    Jul 1, 2025, 00:00

  • MSR38 GenAI Goes to ISPOR: Exploratory, Descriptive Analysis of Generative AI Performance for Summarizing and Synthesizing ISPOR Research Abstracts as Sources

    Jul 1, 2025, 00:00

  • PCR218 Content Validation of the Most Bothersome Symptom - Essential Tremor Questionnaire (MBS-ET): A Cognitive Debriefing Study

    Jul 1, 2025, 00:00

  • HTA7 Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans

    Jul 1, 2025, 00:00

  • RWD79 Retrospective Analysis of Cannabis Hyperemesis Syndrome (CHS) Using US Electronic Medical Records: Demographics and Clinical Characteristics

    Jul 1, 2025, 00:00

  • RWD14 Estimating Healthcare Resource Utilization and Direct Costs of Chronic Myeloid Leukemia in the Brazilian Public Health System

    Jul 1, 2025, 00:00

  • Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States

    Jul 1, 2025, 00:00

  • PCR231 Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling

    Jul 1, 2025, 00:00

  • HSD69 Patient Characteristics and Treatment Patterns in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • EPH102 Changes in the Prevalence of Diabetes Mellitus in Pregnancy : A Nationwide Analysis From Hungary

    Jul 1, 2025, 00:00

  • P63 Balancing Innovation and Affordability: Analyzing the Cost of Drugs for Rare Diseases in Canada

    Jul 1, 2025, 00:00

  • CO93 Real-World Healthcare Resource Utilization in Patients with Idiopathic Pulmonary Fibrosis initiating Antifibrotic Therapy in the Medicare Fee-For-Service Population

    Jul 1, 2025, 00:00

  • PCR232 Patient's Experience of Ulcerative Colitis: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • MSR19 An Open-Source LLM Framework For Transparent Data Extraction From Research Papers

    Jul 1, 2025, 00:00

  • HSD111 Provider perspectives on the DREAMM-7 Trial Results and Belantamab Mafodotin (belamaf) in Combination with Bortezomib and Dexamethasone (B-Vd) as a Potential Treatment for Patients with Relapsed or Refractory Multiple Myeloma (R/R MM ...

    Jul 1, 2025, 00:00

  • EPH2 National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey

    Jul 1, 2025, 00:00

  • PCR59 Exploring Patient Preferences for Systemic Treatments in Psoriasis: A Review of the Literature

    Jul 1, 2025, 00:00

  • EE272 Healthcare Resource Utilization in Patients with Type 1 Diabetes with or without Prior Type 2 Diabetes Misdiagnosis: A Study in a U.S. Managed Care Population

    Jul 1, 2025, 00:00

  • HPR98 Long-term Sustainability of National Essential Medicines Policy in Primary Care System in Rural Southwestern China from 2012-2017: Discrepancies by Facilities and Medicines

    Jul 1, 2025, 00:00

  • PCR211 Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation

    Jul 1, 2025, 00:00

  • EE394 Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population

    Jul 1, 2025, 00:00

  • HPR34 Time to Access Trends of Pharmaceutical Products in EU4 and UK (2019-2021)

    Jul 1, 2025, 00:00

  • RWD133 Building on ‘Contemporary Practice and Considerations for Real-World Data (RWD) Source Identification and Feasibility Assessment’: Mapping Feasibility Criteria Across 46 Real-World Evidence (RWE) Guidelines

    Jul 1, 2025, 00:00

  • CO90 What Does the Pan-Asian Evidence for Malignant Robotic-Assisted Procedures With da Vinci Surgical Systems Say? A systematic Literature Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • HPR1 Trends in FDA Approvals of Cardiovascular Drugs from 1980 to 2024

    Jul 1, 2025, 00:00

  • RWD64 Real-Word Data on Long-Term Outcomes Among Adult Patients With Myopericarditis Related Heart Failure

    Jul 1, 2025, 00:00

  • HPR51 Real-World Evidence in FDA Approvals for Labeling Extension of Drugs and Biologics

    Jul 1, 2025, 00:00

  • PCR69 Examination of Factors Influencing Colorectal Screening Participation

    Jul 1, 2025, 00:00

  • PCR154 Information-seekingbehavior of the Hungarian population regarding colorectal cancer: A Digital Epidemiological Study Using Google TrendsTM

    Jul 1, 2025, 00:00

  • CO78 Clinical and Economic Burden of Non-Obstructive Hypertrophic Cardiomyopathy: A Literature Review

    Jul 1, 2025, 00:00

  • EE255 Economic Impact of Recurrence in High-Risk Early-Stage Estrogen-Receptor Positive (ER+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer (BC)

    Jul 1, 2025, 00:00

  • PCR258 Humanistic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • PT26 Cost-Effectiveness Analysis of Sunvozertinib as a Second-line Treatment for Advanced Non-Small Cell Lung Cancer with EGFR exon20ins Mutation: An Economic Evaluation Based on MAIC

    Jul 1, 2025, 00:00

  • HPR91 Perceptions of Private Health Insurance Among Households in a Small Island Developing State (SIDS): The Case of Grenada

    Jul 1, 2025, 00:00

  • CO27 Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in the Front-Line Maintenance Setting for Advanced Ovarian Cancer (OC): A Trial-Level Meta-Analysis

    Jul 1, 2025, 00:00

  • PCR213 Use of Personalized Migraine Summary Reports in a Symptom Tracking Program to Support Migraine Self-Management

    Jul 1, 2025, 00:00

  • EE494 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China

    Jul 1, 2025, 00:00

  • HPR147 Ongoing Accelerated Approval Trends and What It Means for Patients

    Jul 1, 2025, 00:00

  • HTA14 Empowering Healthcare Decision-Making: Leveraging Standardized Template for Enhanced Reliability and Efficiency in Budget Impact Analysis by Health Technology Assessment Agency

    Jul 1, 2025, 00:00

  • RWD103 Real-World Biologic Prescribing Patterns and Reasons for Discontinuation in Patients with UC and CD

    Jul 1, 2025, 00:00

  • EPH29 Prevalence of Claims-Reported Pruritus in Patients With Primary Biliary Cholangitis Overall and Among Those Treated With Obeticholic Acid

    Jul 1, 2025, 00:00

  • MSR79 The Impact of Prior Choice for Between-Study Heterogeneity in Network Meta-Analysis on Model Conclusions

    Jul 1, 2025, 00:00

  • RWD170 The Pen That Makes You Leaner: GLP-1 Prescription Trends for Weight Loss in the US

    Jul 1, 2025, 00:00

  • HPR144 Factors Delaying the Public Listing of New Drugs in Canada

    Jul 1, 2025, 00:00

  • PCR202 An Interim Analysis of the Burden of Influenza Infection on Health-Related Quality of Life and Work Productivity Among Adults in the United States

    Jul 1, 2025, 00:00

  • CO84 Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A retrospective Cohort Study using Electronic Health Record Data

    Jul 1, 2025, 00:00

  • EE391 Investing in Optimized HIV Prevention Among Young Men Who Have Sex With Men in Brazil: Insights From Fiscal Health Modeling

    Jul 1, 2025, 00:00

  • HTA71 The Prevalence of Fractional-Polynomial Network Meta-analyses (fpNMAs) in Supporting Reimbursement Recommendations by Canada's Drug Agency (CDA-AMC)

    Jul 1, 2025, 00:00

  • PCR66 Understanding the Caregiver Experience Through an Exploration of the Literature

    Jul 1, 2025, 00:00

  • EPH173 Baseline Risk of Hospitalization and Mortality in High-Risk Subgroups of a Nirmatrelvir/Ritonavir Treatment-Eligible Population With Mild-to-Moderate COVID-19 in the United States: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • P49 A Health Technology Assessment Framework for Ethics Analysis in Drug Reimbursement Reviews at Canada's Drug Agency

    Jul 1, 2025, 00:00

  • MSR96 GenAI for Critical Appraisal of Evidence for Systematic Literature Reviews (SLRs): A Face-Off between GenAI and Human Reviewers

    Jul 1, 2025, 00:00

  • EE472 Cost-effectiveness Analysis of Ferric Carboxymaltose (Renegy®) for the Treatment of Iron Deficiency Anemia During Pregnancy: The Mexican Social Security Institute (IMSS) Perspective

    Jul 1, 2025, 00:00

  • PT33 Reliability and Validity of EuroQol-5 Dimensions-5 Levels in Patients with Hematologic Malignancies: A Cross-Sectional Study

    Jul 1, 2025, 00:00

  • EE438 Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective

    Jul 1, 2025, 00:00

  • HTA10 Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency

    Jul 1, 2025, 00:00

  • EE343 Systematic Literature Review of the Economic Burden of Illness in Advanced or Metastatic Non-Small Cell Lung Cancer in First-Line

    Jul 1, 2025, 00:00

  • HSD59 Disparities in Tardive Dyskinesia Diagnosis and Treatment Among the US Medicare Population

    Jul 1, 2025, 00:00

  • PCR251 Is There Value in Knowing? Perspectives of Cancer Screening Outcomes Among the US General Population

    Jul 1, 2025, 00:00

  • HSD82 Prisoners’ Preferences for Virtual Care Design and Delivery in the Correctional Setting: A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • MT26 Evaluating the Economic and Environmental Impact of Reprocessed IPC Sleeves for VTE Prophylaxis: a Cost-Consequence Analysis

    Jul 1, 2025, 00:00

  • MSR69 Emerging Trends in AI Applications: Shaping Pharmacoepidemiology and Health Technology Assessments

    Jul 1, 2025, 00:00

  • EE474 Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Guatemala

    Jul 1, 2025, 00:00

  • PT37 Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry

    Jul 1, 2025, 00:00

  • HTA82 Use of Real-World Evidence in HTA Submissions and Cost-Effectiveness Evaluations in Asia

    Jul 1, 2025, 00:00

  • EPH56 Real-World Demographics and Clinical Characteristics of Multiple Myeloma Patients in a Colombian HMO During 2015-2023

    Jul 1, 2025, 00:00

  • PCR153 The Vaccine Activation Measure (VAM™): Validation of a New Segmentation Tool for Understanding Vaccine Hesitance and Confidence

    Jul 1, 2025, 00:00

  • EPH130 Racial/Ethnic Disparities in Pneumococcal Vaccination Rates Among the Elderly: Trends and Associated Factors in the U.S., 2018-2023

    Jul 1, 2025, 00:00

  • HSD44 Cost of Depression Related Mental Healthcare for Youth During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • CO63 Racial Disparities in the Burden of Illness Among Adults with Prostate Cancer in the United States

    Jul 1, 2025, 00:00

  • PT16 Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges

    Jul 1, 2025, 00:00

  • HPR37 Navigating the IRA: Impact of Medicare Part B Rebates on Drug Pricing and Manufacturer Strategies

    Jul 1, 2025, 00:00

  • PCR8 Application of Sentiment Analysis to Aid in Evaluation of Patient Reported Outcome Measures: Analysis of Qualitative Cognitive Debriefing Interviews

    Jul 1, 2025, 00:00

  • EE222 Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico

    Jul 1, 2025, 00:00

  • EE330 Correlation Between Price and Prevalence in Non-Oncology Orphan Products With Recent Trends (2015-2024)

    Jul 1, 2025, 00:00

  • HPR33 Consumption and Expenditure of WHO Essential Medicines for Cancer: Drug Utilization Analysis of 40 Countries and Regions from 2012 to 2022

    Jul 1, 2025, 00:00

  • MSR68 Development of a Discrete-Time-Updating Algorithm to Predict Cannabis Use Disorder Among Arkansas Medical Marijuana Cardholders

    Jul 1, 2025, 00:00

  • RWD166 Use of a Representative Sample of the French National Health Insurance Database (ESND) for Research: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • CO35 Predicted Effectiveness of First- and Second-Line Treatment Sequences in Advanced or Recurrent Endometrial Cancer

    Jul 1, 2025, 00:00

  • MSR65 Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies

    Jul 1, 2025, 00:00

  • PCR27 Transcultural adaptation of the NutriQoL® questionnaire in American English

    Jul 1, 2025, 00:00

  • P46 Probabilistic Attribute Presentation in Discrete Choice Experiments (DCEs): A Review of Current Practice

    Jul 1, 2025, 00:00

  • HSD75 Evaluating the Association Between Medicare Star Ratings Part D Medication Adherence Measures and the Part C Plan All-Cause Readmission Outcome Measure

    Jul 1, 2025, 00:00

  • HTA96 Navigating Evidence Requirements for Joint Clinical Assessment of Orphan and Advanced Therapy Medicinal Products in Europe

    Jul 1, 2025, 00:00

  • HTA18 The Utilization of Qualitative Evidence Synthesis in Brazil’s Public Health System: A Qualitative Analysis

    Jul 1, 2025, 00:00

  • HTA15 Da Vinci Robotic-Assisted Surgery: 5 years of Health Technology Assessment Trends and Recommendations

    Jul 1, 2025, 00:00

  • MSR14 Frailty Indices Using Claims Data - Examples from a Hospitalized Medicare Population

    Jul 1, 2025, 00:00

  • EE248 Healthcare Resource Utilization of Adult Patients with Obesity Before vs. After GLP-1 Treatment in the United States Elective Outpatient Setting

    Jul 1, 2025, 00:00

  • EE235 Assessing Risdiplam Cost-Effectiveness for Spinal Muscular Atrophy Types I, II, and III in Chile

    Jul 1, 2025, 00:00

  • PCR97 Recurrent Patient-Reported Outcome (PRO)-Based Symptomatic Deterioration Predicts Survival and Disease Progression in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC): Post-Hoc Analysis of RATIONALE-315

    Jul 1, 2025, 00:00

  • PCR143 Psychometric Validation of the Modified Low Luminance Questionnaire in Patients With X-Linked Retinitis Pigmentosa

    Jul 1, 2025, 00:00

  • MT12 Patient-Centric Factors in AI Chatbot Adoption for Healthcare

    Jul 1, 2025, 00:00

  • MSR99 Leveraging Social Media Listening and AI: Topic Modeling and RAG Approaches to Analyse Pet Owners' Perspectives on Nonsteroidal Anti-Inflammatory Drugs in Animal Health

    Jul 1, 2025, 00:00

  • HSD51 Premature Treatment Discontinuation Among Previously Untreated Medicare Beneficiaries With Chronic Lymphocytic Leukemia Treated With Oral Targeted Therapies: A Real-World Analysis

    Jul 1, 2025, 00:00

  • CO44 Comparative Risk of Major Adverse Cardiovascular Events among Patients who Initiate Treatment with Acute Migraine Agents

    Jul 1, 2025, 00:00

  • HTA94 Investing in Clinical Guidelines to Enhance Health Technology Assessments and Reimbursement Decisions

    Jul 1, 2025, 00:00

  • EPH13 Exploring Anemia and the Underdiagnosis of Myelofibrosis: Findings From a Real-World Retrospective Cohort

    Jul 1, 2025, 00:00

  • HPR23 The Most Heavily Managed Drug Categories on Part D Formularies

    Jul 1, 2025, 00:00

  • P22 Assessment of Reasoning Agents for building Literature Search Strategies

    Jul 1, 2025, 00:00

  • EPH186 Temporal Trends in Emergency Department Utilization for Opioid Use Disorder in Baltimore, Maryland

    Jul 1, 2025, 00:00

  • RWD56 Hospitalization Risk Among Adults With Atopic Dermatitis in Brazil's Public Health System

    Jul 1, 2025, 00:00

  • RWD60 Evaluating Electronic Data Network and Direct Facility Retrieval Data Sources for Improved Patient Record Capture in Observational Studies

    Jul 1, 2025, 00:00

  • Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses

    Jul 1, 2025, 00:00

  • EE230 The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in Canada

    Jul 1, 2025, 00:00

  • RWD19 Persistence Patterns of Antidepressants in Mood, Anxiety, and Related Disorders: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • MSR73 Augmenting Small Training Datasets Improves Machine Learning Prognostic Performance

    Jul 1, 2025, 00:00

  • CO67 The Potential Long-Term Comparative Effectiveness of Larotrectinib vs Repotrectinib for Treatment of NTRK Gene Fusion-Positive Cancers

    Jul 1, 2025, 00:00

  • CO41 Real-world Clinical And Demographic Characteristics Associated With Progression To Type 2 Diabetes In Patients With Prediabetes

    Jul 1, 2025, 00:00

  • EE412 The Economic Impact of Indwelling Urinary Catheterization on Total Joint Arthroplasty Procedures and Implications for Urinary Catheter Alternatives: A Systematic Review, Analysis, and Model

    Jul 1, 2025, 00:00

  • RWD93 Programmed Death Ligand 1 (PD-L1) Protein Expression Among Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma from Two Oncologic Institutions in Brazil

    Jul 1, 2025, 00:00

  • MSR155 Assessing the Effectiveness of Large Language Models in Automating Systematic Literature Reviews: Findings from Recent Studies

    Jul 1, 2025, 00:00

  • HTA74 Transforming Global Value Dossier (GVD) Drafting: Creation with a Generative Artificial Intelligence (Gen AI)-Driven Coauthoring Accelerator

    Jul 1, 2025, 00:00

  • PCR133 Does Providing Informal Care to Alzheimer’s Dementia Cause High Caregiver Burden: Insights From Malaysia

    Jul 1, 2025, 00:00

  • HTA50 A Reanalysis of Canada's Drug Agency (CDA) Reports: Do Conclusions from Cost-Effectiveness Analyses Using Quality-Adjusted Life-Years (QALYs) Hold When Evaluating with Equal Value of Life-Years Gained (evLYG)?

    Jul 1, 2025, 00:00

  • RWD81 The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study

    Jul 1, 2025, 00:00

  • HPR40 Determinants of FDA Review Duration for Novel Therapeutics: Analysis of Regulatory Designations and Product Characteristics

    Jul 1, 2025, 00:00

  • EPH131 Estimating US Cancer Prevalence With Community Oncology EHR-Based Datasets via National Benchmarks From SEER and NPCR

    Jul 1, 2025, 00:00

  • HPR52 Digital twins: Hype or Hope for Better Health Outcomes?

    Jul 1, 2025, 00:00

  • HPR61 US Food and Drug Administration Authorizations of Therapeutic Biologics and Biosimilars, 1980-2024

    Jul 1, 2025, 00:00

  • SA7 Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data

    Jul 1, 2025, 00:00

  • EE250 Quantifying Spillover Impacts: Effect of Novel Therapies for IgA Nephropathy on Patients Awaiting Kidney Transplant

    Jul 1, 2025, 00:00

  • HTA26 The Impact of CDA-AMC Sequential Analysis on Decision-Making in Oncology

    Jul 1, 2025, 00:00

  • HPR150 Review of Cell Therapy Access Landscape

    Jul 1, 2025, 00:00

  • PCR210 Association Between Caregiver Quality of Life and the Care Provided to Adults With Severe Visual Impairments: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HPR86 Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis

    Jul 1, 2025, 00:00

  • RWD49 Development and Application of a Novel Framework for Clinician Stakeholder Engagement in Real-world Data (RWD) Studies

    Jul 1, 2025, 00:00

  • EE453 Cost-Effectiveness Analyses of Repotrectinib in TKI-Naïve Patients with ROS1+ Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • PCR99 Mapping between the HUI2/HUI3 and the PROPr in the United States

    Jul 1, 2025, 00:00

  • PCR87 Analysis of the Effect of Trofinetide Treatment on the Domain and Item-Level Responses of the Rett Syndrome Behavior Questionnaire Using Data From the LAVENDER Trial

    Jul 1, 2025, 00:00

  • EE338 Avoidable Costs by the Inclusion Ff Finerenone in Terms of Hospitalization Due to Heart Failure (HF) and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jul 1, 2025, 00:00

  • RWD61 Assessing Antipsychotic Adherence in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real-World Data

    Jul 1, 2025, 00:00

  • HTA12 Navigating Uncertainty in Overall Survival Data: Insights from Positive Canadian HTAs on Lung Cancer Therapies

    Jul 1, 2025, 00:00

  • EE339 Evaluating the Impact of Predictive Variables on Individual Biosimilar US Market Share

    Jul 1, 2025, 00:00

  • PCR21 Health-Related Quality of Life and Associated Factors Among Patients With Chronic Diseases in Hainan Province, China

    Jul 1, 2025, 00:00

  • EE374 Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan

    Jul 1, 2025, 00:00

  • HPR42 The Emerging Potential of International Reference Pricing (IRP) in the US: An Analysis of Trends, Challenges, Opportunities and learnings from Europe

    Jul 1, 2025, 00:00

  • EPH156 Evaluation of Chronic Conditions and Severe Outcomes in Adults Aged 18-59 Years With Medically Attended RSV Illness Using U.S. Commercial Claims Data

    Jul 1, 2025, 00:00

  • HSD49 Diagnosis and Treatment Journey of Patients With Atrial Fibrillation Prior to Stroke Occurrence

    Jul 1, 2025, 00:00

  • HPR67 Canada’s Evolving Market for Biosimilars and What It Means for Payers

    Jul 1, 2025, 00:00

  • EE489 Costs of Initiated Potentially Inappropriate Medication in 2021-2022 in Quebec, Canada

    Jul 1, 2025, 00:00

  • HTA29 Who Benefits From Technological Progress Among People With Type 1 Diabetes? Improvements in Glycemic Outcomes After CGM Adoption by Sociodemographic Characteristics

    Jul 1, 2025, 00:00

  • MSR140 Adapting PRISMA For System Dynamics Models In Healthcare: A Case Study Of Transcatheter Aortic Valve Implantation In Canada

    Jul 1, 2025, 00:00

  • EPH26 Mortality due to Road Traffic Injuries in Colombia Before and After SARS-CoV-2 (2018-2022)

    Jul 1, 2025, 00:00

  • EPH178 Estimates of the Public Health Impact of Norovirus Vaccination for Older Adults in the United States

    Jul 1, 2025, 00:00

  • EE267 Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling

    Jul 1, 2025, 00:00

  • EE210 Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • PCR245 Inclusion of Health-Related Quality of Life (HRQoL) and Other Patient-Reported Outcomes (PROs) in the United States Food and Drug Administration (FDA) Labels

    Jul 1, 2025, 00:00

  • PCR118 Real-World Evaluation of Trastuzumab Deruxtecan Administration, Compliance, and Dose Utilization in Chinese Patients With HER2-Positive Advanced Breast Cancer

    Jul 1, 2025, 00:00

  • EE240 Economic Impact of Blister-Packaging on Medication Adherence in First-Line Multiple Myeloma Treatment

    Jul 1, 2025, 00:00

  • MT7 Latent Class Analysis (LCA) to Identify Medical Device Usage in Real-World Data

    Jul 1, 2025, 00:00

  • P56 Biosimilar Optimization in Community Oncology Practices

    Jul 1, 2025, 00:00

  • MSR45 Explore the Prognostic Factors of Survival Outcomes in Newly Diagnosed Multiple Myeloma Who Are Not Transplant Eligible

    Jul 1, 2025, 00:00

  • MSR46 Evaluation of Machine Learning Assisted Title and Abstract Screening in 5 Clinical Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • HTA33 Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE

    Jul 1, 2025, 00:00

  • EE434 An Economic Model to Estimate Costs of Adverse Events in Patients Treated With Lisocabtagene Maraleucel (liso-cel), Axicabtagene Ciloleucel (axi-cel), or Tisagenlecleucel (tisa-cel) for Relapsed/Refractory Follicular Lymphoma

    Jul 1, 2025, 00:00

  • CO87 Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study

    Jul 1, 2025, 00:00

  • HTA8 Trends in Indirect Treatment Comparison (ITC) Methods Used in Reimbursement Submissions in Canada and the US

    Jul 1, 2025, 00:00

  • PCR19 The Unseen Progress: How PROs May Overlook the Value of Slowing Degenerative Decline

    Jul 1, 2025, 00:00

  • CO94 Impact of Individualized Neoantigen Therapies on Health, Productivity and Health System Capacity Outcomes in Resectable Melanoma in England

    Jul 1, 2025, 00:00

  • HTA83 Enhancing Health Technology Assessment With Data Transportability Analyses: Addressing Bias and Generalizability Challenges In Non-Local Real-World Evidence

    Jul 1, 2025, 00:00

  • EE216 Health and Economic Impact Analysis of Uncontrolled Hemophilia Patients in Colombia

    Jul 1, 2025, 00:00

  • HPR47 Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans

    Jul 1, 2025, 00:00

  • HSD37 Characteristics of Patients Enrolled in a Pharmacist Managed Rare Disease Program: Highlighting National Diversity and Representation

    Jul 1, 2025, 00:00

  • EE516 Cost-Effectiveness Analysis of Adjuvant Pembrolizumab Versus Standard-of-Care (SOC) Immunotherapies (High-Dose interferon Alfa 2-b or Ipilimumab) in High-Risk Resected Melanoma in United States (US)

    Jul 1, 2025, 00:00

  • PCR6 Impacts of Annual Wage on Insulin Adherence in Diabetes

    Jul 1, 2025, 00:00

  • EPH187 Association of Sleep Disturbances With Mild Cognitive Impairment Among Adults in the US

    Jul 1, 2025, 00:00

  • RWD106 Cardiovascular Morbidity and Mortality Among ATTR-CM Patients Treated with Tafamidis in the US

    Jul 1, 2025, 00:00

  • EE510 An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States

    Jul 1, 2025, 00:00

  • EE229 Cost-Effectiveness Analysis of First-Line Tremelimumab Plus Durvalumab Versus Sorafenib in Unresectable Hepatocellular Carcinoma

    Jul 1, 2025, 00:00

  • EE327 Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model

    Jul 1, 2025, 00:00

  • HTA44 Reimbursement Outcomes for EMA Conditionally Authorized Orphan Drugs (2022-2023): Implications for Joint Clinical Assessment Requirements

    Jul 1, 2025, 00:00

  • PCR219 Quality-of-Life, Symptom Burden, and Tolerability in Frail Patients without Caregivers in Real-world Oncology Practice

    Jul 1, 2025, 00:00

  • P57 Frequency of ICER Miscalculation and Misinterpretation in Published Cost-Effectiveness Analysis Comparing More Than Two Alternatives

    Jul 1, 2025, 00:00

  • RWD82 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Bipolar I Disorder

    Jul 1, 2025, 00:00

  • RWD101 Epidemiology, Demography and Comorbidities of Patients With Osteoporosis at Very High Risk of Fracture in China

    Jul 1, 2025, 00:00

  • PCR241 Beyond Overall Survival: Advancing the Understanding and Use of Surrogate Endpoints in Oncology

    Jul 1, 2025, 00:00

  • PCR23 A Growing Trend: The Expanding Use of Patient-reported Outcome Measures (PROMs) in Clinical Trials (2008-2023)

    Jul 1, 2025, 00:00

  • PT19 Timing of Health Technology Assessment in the United States: An Evaluation of ICER Reviews Over Seven Years

    Jul 1, 2025, 00:00

  • HSD110 Real-World Subcutaneous Monoclonal Antibody Use Trends for Oncology in the US

    Jul 1, 2025, 00:00

  • EE299 Cost Per PFS-Based Responder for TKI-Naive Patients Receiving Repotrectinib or Entrectinib in ROS1 Fusion Positive Non-Small Cell Lung Cancer (NSCLC) in the United States (US)

    Jul 1, 2025, 00:00

  • EPH62 Estimation of Treatment Eligible Patients With Transthyretin Cardiac Amyloidosis Within a Health Plan

    Jul 1, 2025, 00:00

  • PCR253 Psychometric Evaluation of the ASCOT-SCT4, a Preference-Based Quality of Life Instrument for Social Care Service Users in Hong Kong: An Application of Item Response Theory

    Jul 1, 2025, 00:00

  • RWD13 Real-World Use of Biologics in the Treatment of Psoriasis and Ankylosing Spondylitis in China: The Case of Secukinumab

    Jul 1, 2025, 00:00

  • CO1 Assessment of Disease Progression and Healthcare Resource Utilization Associated with Duchenne Muscular Dystrophy: A Retrospective Observational Study Using the Optum Market Clarity Database

    Jul 1, 2025, 00:00

  • HPR90 Value Communications With US Payers: The Value of Storytelling

    Jul 1, 2025, 00:00

  • EPH48 Variables Statistically Associated With Mental Health Among United States Adults With Asthma in the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • MT28 Harnessing Digital Measures of Physical Function in Neurological Conditions: Findings From a Targeted Literature Review

    Jul 1, 2025, 00:00

  • MSR116 Trends in Current Smoker Profiles Among US Adults From 2019-2024: An Unsupervised Clustering Analysis

    Jul 1, 2025, 00:00

  • Editorial Board

    Jun 3, 2025, 09:22

  • Costs and Health Outcomes in Economic Evaluations of Person-Centered Care: A Systematic Review

    Jun 1, 2025, 00:00

  • Use of Real-World Evidence in Health Technology Reassessments Across 6 Health Technology Assessment Agencies

    Jun 1, 2025, 00:00

  • Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?

    Jun 1, 2025, 00:00

  • Understanding the Economic Value of Interventions Addressing Perinatal Mental Health Problems: A Literature Review and Methodological Considerations

    Jun 1, 2025, 00:00

  • Quantifying Low-Value Care in Germany: An Observational Study Using Statutory Health Insurance Data From 2018 to 2021

    Jun 1, 2025, 00:00

  • The Value of Positron Emission Tomography for Confirmation of Alzheimer’s Disease in the Era of Amyloid-Targeting Therapies

    Jun 1, 2025, 00:00

  • Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices

    Jun 1, 2025, 00:00

  • US Drug Pricing Patterns Before Loss of Exclusivity

    Jun 1, 2025, 00:00

  • When Do Value-Based Contracts Add Value? Insights From Probabilistic Simulations

    Jun 1, 2025, 00:00

  • The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level

    Jun 1, 2025, 00:00

  • Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report

    Jun 1, 2025, 00:00

  • Table of Contents

    Jun 1, 2025, 00:00

  • Quality-Adjusted Life Expectancy by Socioeconomic Disadvantage and Remoteness Area: Population Norms for Australia

    Jun 1, 2025, 00:00

  • A Person-Centered eHealth Intervention for Patients With Common Mental Disorders: Cost-Effectiveness Analysis Within a Randomized Controlled Trial

    Jun 1, 2025, 00:00

  • A Factual Inaccuracy Noted in the Conclusions Specifically Regarding the Novelty of the Author’s Work in the Middle East

    Jun 1, 2025, 00:00

  • Performance of the EQ-5D-5L With Skin Irritation and Self-Confidence Bolt-On Items in Patients With Urticaria

    Jun 1, 2025, 00:00

  • Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations

    Jun 1, 2025, 00:00

  • Drop the “M”: Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods

    Jun 1, 2025, 00:00

  • The Health Inequality Impact of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2025, 00:00

  • Can Adolescents Value the EQ-5D-Y-5L and EQ-5D-5L, and How Do the Values Compare? A Feasibility Study

    Jun 1, 2025, 00:00

  • A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland

    Jun 1, 2025, 00:00

  • Editorial Board

    May 7, 2025, 15:10

  • Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases

    May 1, 2025, 00:00

  • Are Updated COVID-19 Vaccines Still Relevant for All Adult Age Groups? An Economic Evaluation of the Monovalent XBB.1.5 Vaccine in Australia

    May 1, 2025, 00:00

  • Do Machine Learning Approaches Perform Better Than Regression Models in Mapping Studies? A Systematic Review

    May 1, 2025, 00:00

  • A Comparison of International Modeling Methods for Evaluating Health Economics of Colorectal Cancer Screening: A Systematic Review

    May 1, 2025, 00:00

  • Public Health Supports Whole Health

    May 1, 2025, 00:00

  • Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer

    May 1, 2025, 00:00

  • Development and Testing of the Psychometric Properties of 20 Bolt-On Items for the EQ-5D-5L Across 31 Rare Diseases

    May 1, 2025, 00:00

  • Table of Contents

    May 1, 2025, 00:00

  • Newer Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Improved Glycemic Control in US Adults With Type 2 Diabetes: A Population-Level Time Series Analysis

    May 1, 2025, 00:00

  • What Does "Whole Health" Really Mean for Health Economics and Outcomes Research?

    May 1, 2025, 00:00

  • Whole Health: A Global Perspective

    May 1, 2025, 00:00

  • Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions

    May 1, 2025, 00:00

  • Managing Uncomplicated Singleton Breech Pregnancy Using the OptiBreech Collaborative Care Pathway: Early Economic Model and Value of Information Analysis

    May 1, 2025, 00:00

  • Capturing the Additional Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists Beyond the Control of Traditional Risk Factors in People With Diabetes

    May 1, 2025, 00:00

  • The Price Effects of Biosimilars in the United States

    May 1, 2025, 00:00

  • An Acquired Taste: Latent Class Analysis to Compare Adolescent and Adult Preferences for EQ-5D-Y-3L Health States

    May 1, 2025, 00:00

  • How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report

    May 1, 2025, 00:00

  • Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report

    May 1, 2025, 00:00

  • Taking Health Economics and Outcomes Research Forward: Expanding the Definition of Value to Include Whole Health

    May 1, 2025, 00:00
  • 1
  • 2
  • 3
  • 4 (current)
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »